through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Branded Pharmaceuticals segment conducts certain operations in the U. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products.

The opinions expressed in this article are those of the writer, subject to the Publishing Guidelines. On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. Read More: Penny Stocks - How to Profit Without Getting Scammed If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that ’s writers disclose this fact and warn readers of the risks. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. Target (TGT) Stock Slips on Earnings Miss.Tucker Carlson Gives the New Anti-ESG DRLL ETF a Big Boost.What Is Going on With Meme Stocks GME, AMC Today?.You can find all that news at the following links! More Wednesday Stock Market News Energy ETF (NYSEARCA: DRLL) is rising and more. That includes what has shares of meme stocks moving, why Strive U.S. InvestorPlace has all of the latest stock market coverage traders need to know about today. Investors on the lookout for more of the latest stock market news are in luck! “By definitively addressing the more than $8 billion of debt that has burdened our balance sheet and establishing a pathway to closure with respect to the thousands of opioid-related and other lawsuits that the Company has been defending at an unsustainable cost, we will be able to move forward as a new Endo and reach our full potential.”ĮNDP stock is down more than 10% as of Wednesday morning as well as down 91% since the start of the year. The deal also includes voluntary trusts of $550 million over the next 10 years to cover future opioid litigation.Įndo President and CEO Blaise Coleman said the following about the agreement: The details of the agreement include a $6 billion credit bid to acquire the company and provisions for retaining all active Endo employees.

The agreement would reduce its debt,as well as cover remaining litigation related to opioid lawsuits. This agreement is with “holders of more than a majority” of its first lien debt. To go along with that news, Endo International recently revealed a restructuring support agreement (RSA). This would also require Endo to relinquish certain documents and stop promoting its opioids. Massachusetts Attorney General Maura Healey said the company may end up paying a settlement of $450 million. The big reason behind this filing is the lawsuits Endo is facing over its alleged role in the U.S. Source: OleksandrShnuryk / Įndo International (NASDAQ: ENDP) stock is taking a beating on Wednesday after the company filed for bankruptcy protection.

Endo pharmaceuticals market cap